We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
HCW Biologics announced terms for its IPO on Wednesday, saying it plans to raise $50 million by offering 5.6 million shares at a price range of $8 to $10, reported Renaissance Capital.